Open access
Open access
Powered by Google Translator Translator

Randomized Trial: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19

17 Jun, 2020 | 02:49h | UTC

Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 – Recovery Trial

Commentaries: Coronavirus breakthrough: dexamethasone is first drug shown to save lives – Nature AND WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients – World Health Organization AND Major study finds common steroid reduces deaths among patients with severe Covid-19 – STAT AND Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 – University of Oxford AND Coronavirus: Dexamethasone proves first life-saving drug – BBC

 

Related Commentary on Twitter

 


Stay Updated in Your Specialty

 

No spam, just news.